NasdaqGM - Nasdaq Real Time Price • USD
Merrimack Pharmaceuticals, Inc. (MACK)
As of 2:47 PM EDT. Market Open.
All SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
Performance Overview
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is S&P 500
Return | MACK | S&P 500 |
---|---|---|
YTD | +9.66% | +4.06% |
1-Year | +16.61% | +19.46% |
3-Year | +109.47% | +18.59% |